Medication info
Rosuvastatin Calcium 20 mg Tablet

Rosuvastatin Calcium 20 mg Tablet

Prescription medicationTabletOral
Ingredient · strength
Rosuvastatin Calcium›20.8mg / 1 tablet
Manufacturer / importer
Korea United Pharmaceutical Co., Ltd.
Appearance
Pink, convex, round film-coated tablets
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201403469 · Approved 2014.07.29 · Insurance code 644308790

Summary

Main use
Treatment of dyslipidemia; prevention of cardiovascular disease; inhibition of the progression of atherosclerosis
Who takes it
Adults · Children
Adult dose
The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, and most patients are controlled with this dose. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 milligrams per day. Elderly patients: Dose adjustment is not required. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution should be exercised when administering 20mg of this medicine to patients with moderate renal impairment. Ethnicity: Since systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medicine is contraindicated in some of these patients.
Child dose
Ages 10 to 17 years: The usual dose range is 5 milligrams to 20 milligrams once daily. There are no clinical data on doses above 20 milligrams in pediatric patients. Under 10 years of age: Safety and efficacy have not been established.

Ingredients

Manufacturer
Korea United Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of dyslipidemia; prevention of cardiovascular disease; inhibition of the progression of atherosclerosis

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • combined hyperlipidemia
  • homozygous familial hypercholesterolemia
  • hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • primary dysbetalipoproteinemia
  • coronary heart disease
  • stroke
  • myocardial infarction
View approved original text

This medicine aids patients with hypercholesterolemia and hyperlipidemia when dietary and exercise controls are inadequate. It is also used as an adjunct in patients with familial hypercholesterolemia, helping to lower total cholesterol and LDL-cholesterol levels, thereby delaying the progression of atherosclerosis. Particularly, it enhances efficacy when used alongside diet in pediatric patients aged 10 to 17 with high cholesterol levels. Additionally, it serves as a dietary adjunct in patients with primary dysbetalipoproteinemia. Furthermore, it helps reduce the risk of stroke, myocardial infarction, and artery revascularization in middle-aged patients with elevated high-sensitivity C-reactive protein and cardiovascular risk factors. It is used to improve cardiovascular health due to these effects.

How to take

Adult dose

The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, and most patients are controlled with this dose. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 milligrams per day. Elderly patients: Dose adjustment is not required. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution should be exercised when administering 20mg of this medicine to patients with moderate renal impairment. Ethnicity: Since systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this medicine is contraindicated in some of these patients.

Child dose

Ages 10 to 17 years: The usual dose range is 5 milligrams to 20 milligrams once daily. There are no clinical data on doses above 20 milligrams in pediatric patients. Under 10 years of age: Safety and efficacy have not been established.

Precautions

This medication should not be administered to certain patients. For example, individuals allergic to this medication, those with active liver disease, muscle disorders, and severe renal failure should not take this medication. Pregnant or breastfeeding women, and fertile women not using appropriate contraception should also avoid this medication, and women of childbearing potential should only take it if they are aware of the risks to the fetus and have reduced the possibility of pregnancy. Patients at high risk for myopathy or rhabdomyolysis should be particularly cautious, and high doses of this medication are contraindicated. Risk factors include moderate renal impairment, hypothyroidism, a history of muscle disorders, alcohol dependence, certain ethnicities (Asians), and concomitant use with fibrate medications. This medication contains lactose, so patients with lactose intolerance or related genetic diseases should not take it. Patients with liver function impairment or a history of alcohol abuse should undergo regular liver function tests before and during treatment with this medication, and patients with hypercholesterolemia due to thyroid dysfunction or nephrotic syndrome should use this medication after treatment of the underlying disease. Muscle-related side effects such as myalgia, myopathy, and rarely rhabdomyolysis have been reported; therefore, if any muscle pain, weakness, or cramps occur during treatment, immediate consultation with a physician is necessary. Particularly, if there is a significant increase in muscle enzyme levels, discontinuation of the medication should occur. It is advisable to discontinue this medication during acute severe conditions or significant physical stress situations. This medication can rarely cause severe muscle weakness or ocular muscle weakness, and usage should be terminated if these symptoms emerge. The risk of muscle side effects can increase when used in conjunction with specific other medications; therefore, it is crucial to consult a doctor or pharmacist about concomitant medications. High doses may result in temporary proteinuria, necessitating renal function tests. Asian patients may require dosage adjustments due to potentially higher drug concentrations. Pediatric and adolescent patients should be monitored for growth and sexual development effects. While this medication is generally considered safe, it is important to consult healthcare professionals immediately if any abnormal symptoms are observed during treatment.

Side effects

Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS), lichenoid drug eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disturbances, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, abnormal liver function tests, syncope, generalized pain, fatigue

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is best to maintain storage temperatures between 1 and 30 degrees Celsius to ensure the drug's efficacy and safety are preserved over time.

Appearance and packaging

Appearance

Pink, convex, round film-coated tablets

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.